Treatment of obesity: need to focus on high risk abdominally obese patients
- PMID: 11264213
- PMCID: PMC1119905
- DOI: 10.1136/bmj.322.7288.716
Treatment of obesity: need to focus on high risk abdominally obese patients
Figures





Comment in
-
Abdominal obesity and the "hypertriglyceridaemic waist" phenotype.BMJ. 2001 Mar 24;322(7288):687-9. doi: 10.1136/bmj.322.7288.687. BMJ. 2001. PMID: 11264193 Free PMC article. No abstract available.
Similar articles
-
Abdominal obesity and the "hypertriglyceridaemic waist" phenotype.BMJ. 2001 Mar 24;322(7288):687-9. doi: 10.1136/bmj.322.7288.687. BMJ. 2001. PMID: 11264193 Free PMC article. No abstract available.
-
Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.Diabetes Metab. 2003 Sep;29(4 Pt 2):6S53-61. doi: 10.1016/s1262-3636(03)72788-8. Diabetes Metab. 2003. PMID: 14502101 Review.
-
Adiposity and fat distribution outcome measures: assessment and clinical implications.Obes Res. 2002 Nov;10 Suppl 1:14S-21S. doi: 10.1038/oby.2002.184. Obes Res. 2002. PMID: 12446853 Review. No abstract available.
-
Health consequences of visceral obesity.Ann Med. 2001 Nov;33(8):534-41. doi: 10.3109/07853890108995963. Ann Med. 2001. PMID: 11730160 Review.
-
Dyslipidemia of central obesity and insulin resistance.Diabetes Care. 1999 Apr;22 Suppl 3:C10-3. Diabetes Care. 1999. PMID: 10189557 Review. No abstract available.
Cited by
-
Fitness Level is Associated with Sex-Specific Regional Fat Differences in Normal Weight Young Adults.J Endocrinol Diabetes. 2015;2(2):5. doi: 10.15226/2374-6890/2/3/00122. Epub 2015 May 20. J Endocrinol Diabetes. 2015. PMID: 27054196 Free PMC article.
-
Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation.Am J Physiol Endocrinol Metab. 2015 May 1;308(9):E770-7. doi: 10.1152/ajpendo.00510.2014. Epub 2015 Feb 24. Am J Physiol Endocrinol Metab. 2015. PMID: 25714674 Free PMC article.
-
CB1 antagonists for obesity--what lessons have we learned from rimonabant?Nat Rev Endocrinol. 2009 Nov;5(11):633-8. doi: 10.1038/nrendo.2009.197. Nat Rev Endocrinol. 2009. PMID: 19844251
-
"A heart for Vienna"--the prevention program for the big city. Blue-collar workers as a special target group.Wien Med Wochenschr. 2006 Oct;156(19-20):552-7. doi: 10.1007/s10354-006-0340-3. Wien Med Wochenschr. 2006. PMID: 17103294
-
Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results From the German Male Sex Study.Sex Med. 2019 Mar;7(1):26-34. doi: 10.1016/j.esxm.2018.11.004. Epub 2019 Jan 9. Sex Med. 2019. PMID: 30638828 Free PMC article.
References
-
- Bray GA, Bouchard C, James WPT, editors. Handbook of obesity. New York: Marcel Dekker; 1998.
-
- National Heart, Lung, and Blood Institute/National Institutes of Diabetes and Digestive and Kidney Diseases. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. The evidence report. Bethesda: National Institutes of Health; 1998. pp. 1–228.
-
- WHO Consultation on Obesity. Preventing and managing the global epidemic. Geneva: World Health Organization; 1997. pp. 1–276. - PubMed
-
- Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis. 1972;25:329–343. - PubMed
-
- Vague J. La différenciation sexuelle, facteur déterminant des formes de l'obésité. Presse Med. 1947;30:339–340. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical